Clinical Trial Update: Prasugrel With Lower Dose - Loading Dose [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a lower loading dose of prasugrel in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: Dong-A University | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED